banner
Inquiry

Cat. No.: X25-06-LY002

Azvudine hydrochloride

Synonym: 1333126-31-0; 4-Amino-1-[(2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride; Azvudine hydrochloride; Azvudine (hydrochloride); 4-Amino-1-[(2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

  • CAS Number: 1333126-31-0
  • Compound CID: 54579399
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Azvudine hydrochloride is a nucleoside analog with antiviral activity. It blocks viral replication by inhibiting the viral RNA-dependent RNA polymerase (RdRp) and belongs to nucleoside reverse transcriptase inhibitors.
Molecular Weight
322.68
Molecular Formula
C9H12ClFN6O4
Form
Solid
Purity
≥95.0%, determined by LC-MS.
Solubility
Water: 125 mg/mL (387.38 mM)
Identity
Confirmed by NMR and LC-MS.
Applications
Azvudine hydrochloride as a nucleoside compound, it can be used to study the mechanism of viral replication and the antiviral mechanism of drugs.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0